| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.16 | 1e-06 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.17 | 2e-06 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-06 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.14 | 2e-06 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.16 | 5e-06 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | -0.17 | 6e-06 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.16 | 6e-06 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.14 | 7e-06 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.2 | 9e-06 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.14 | 1e-05 |